Loading
Loading…
Loading…
| # | Schedule | Awarded To | Bids | Value |
|---|---|---|---|---|
| 1 | Schedule 1 | ALBINO LIFESCIENCES PRIVATE LIMITED | 1 | ₹14.7 L |
| 2 | Schedule 2 | ALBINO LIFESCIENCES PRIVATE LIMITED | 5 | ₹14.7 L |
| 3 | Schedule 3 | ALBINO LIFESCIENCES PRIVATE LIMITED | 5 | ₹14.7 L |
Tender Value
Refer Docs
EMD Value
Exempted
Closing Date
3 Dec 2024, 3:00 pmClosed
DRUGS AND MEDICINE
7109873
GEM/2024/B/5582665
Two Packet Bid
Inj Luspatercept 75 mg,Tab Olaparib 150 mg,Ferric carboxymaltose 50 mg per ml 10 ml vial for inj,Re
30 days
Karnataka; Belagavi
Item wise evaluation
BOQ
7 documents required · 7 mandatory
1 yrs
₹3
20%
Exempted
9 Dec 2024
12 Nov 2024
3 Dec 2024
| Item No | Item Title | Qty | Unit | Consignee | Delivery (days) | Spec |
|---|---|---|---|---|---|---|
| 1 | Inj Luspatercept 75 mg | 17 | No | BELGAUM | 30 | |
| 2 | Tab Olaparib 150 mg | 1,350 | No | BELGAUM | 30 | |
| 3 | Ferric carboxymaltose 50 mg per ml 10 ml vial for inj | 30 | Vial | BELGAUM | 30 | |
| 4 | Recombinant Growth harmone 5 mg 3 point 33mg per ml | 37 | Vial | Recombinant Varicella Zoster BELGAUM Virus Glycoprotein E | 30 | - |
| 5 | Recombinant varicella zoster virus glycoprotein E Antigen 0 point 5 ml | 1 | No | BELGAUM | 30 |
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
bid_7109873.pdf
GEM_BID
specification_28_2024-11-07-11-57-56_07be59d4735595915c64cdcf11312682.pdf
BOQ
boq_item_sample_file-3_2024-11-07-11-57-56_1033ffc9dbe2647c57ea1b8e0fc6db40.csv
BOQ
ATC_73aec16e-94f0-41ce-abf21730986774808_Dglpechs.pdf
OTHER
list-of-categories-where-trials-are-allowed_1712126171.pdf
OTHER
gtc.pdf
OTHER
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .